Global Health
Latest news, analysis, and updates on Global Health from A47 News.
9 stories in World · Updated live
Moderna and Merck report positive Phase 3 results for personalized mRNA melanoma vaccine
On August 19, 2026, Moderna and Merck announced positive topline results from the Phase 3 INTerpath-001 trial for their personalized mRNA cancer vaccine, showing significant improvements in patient outcomes. This announcement follows prior promising Phase 2 data and reflects the growing validation of mRNA technology in oncology. If approved, this could lead to a new standard of care in melanoma treatment and expand the application of mRNA vaccines beyond infectious diseases.
Sheikh Mohammed bin Rashid Al Maktoum Funds Treatment for Jordanian Girl with Spinal Muscular Atrophy
Sheikh Mohammed bin Rashid Al Maktoum has funded the complete treatment costs for Katia Abu Al-Saud, a Jordanian girl suffering from spinal muscular atrophy. This humanitarian intervention was triggered by a viral family appeal for the high-cost gene therapy that is unavailable in Jordan. The long-term implication is the UAE's continued role as a regional leader in humanitarian medical support, enhancing its reputation in advanced pediatric care.
DR Congo Ebola Outbreak Declared Public Health Emergency of International Concern
The 2026 Ebola outbreak in the Democratic Republic of the Congo has escalated to nearly 5,300 confirmed cases and over 2,500 deaths, marking it the deadliest in the nation's history. This rapid increase is attributed to ongoing conflict, insecurity, and population movements, which have hindered containment efforts. Long-term implications include heightened regional health risks and increased international cooperation for surveillance and response measures.
Harvard Medical School Settles $53 Million Lawsuit Over Stolen Donated Human Remains
Harvard Medical School has reached a $53 million class action settlement regarding the theft and sale of donated human remains by a former morgue manager. This settlement follows a series of lawsuits initiated by the families of donors after the manager's indictment and guilty plea for his actions between 2018 and 2022. The long-term implication includes Harvard's commitment to enhance oversight of its Anatomical Gift Program and establish a scholarship fund in honor of anatomical donors starting in 2027-28.
Latest Stories
Abu Dhabi Deploys 18 Smart Ambulances for Enhanced Emergency Medical Services
Abu Dhabi has launched a fleet of 18 smart ambulances equipped with real-time data integration to improve emergency care. This initiative is driven by the need to enhance patient outcomes by ensuring that ambulances are dispatched to hospitals based on real-time capacity and specialist availability. The long-term implication is a significant advancement in the efficiency of emergency medical services in the UAE, aligning with broader healthcare digitalization efforts.
DR Congo Ebola Outbreak Declared Public Health Emergency of International Concern
The 2026 Ebola outbreak in the Democratic Republic of the Congo has escalated to nearly 5,300 confirmed cases and over 2,500 deaths, marking it the deadliest in the nation's history. This rapid increase is attributed to ongoing conflict, insecurity, and population movements, which have hindered containment efforts. Long-term implications include heightened regional health risks and increased international cooperation for surveillance and response measures.
Kuwait Bans Non-Scientific Psychotherapy Practices Nationwide
Kuwait's Ministry of Health has enacted Ministerial Decision 225 of 2026, banning non-scientific psychotherapy methods such as Reiki and EFT. This regulatory shift is driven by a growing demand for evidence-based mental health services and aims to standardize practices across the country. The long-term implication may include a significant reduction in alternative therapy providers and a potential shift in mental health service dynamics in the region.
Moderna and Merck report positive Phase 3 results for personalized mRNA melanoma vaccine
On August 19, 2026, Moderna and Merck announced positive topline results from the Phase 3 INTerpath-001 trial for their personalized mRNA cancer vaccine, showing significant improvements in patient outcomes. This announcement follows prior promising Phase 2 data and reflects the growing validation of mRNA technology in oncology. If approved, this could lead to a new standard of care in melanoma treatment and expand the application of mRNA vaccines beyond infectious diseases.